open access

Vol 13, No 7 (2006): Folia Cardiologica
Original articles
Published online: 2006-09-15
Get Citation

The effect of anti-tachycardia atrial pacing in patients with recurrent paroxysmal atrial fibrillation

Katarzyna Gepner, Maciej Sterliński, Mariusz Pytkowski, Aleksander Maciąg, Andrzej Przybylski, Alicja Kraska, Michał Lewandowski, Hanna Szwed
Folia Cardiol 2006;13(7):590-595.

open access

Vol 13, No 7 (2006): Folia Cardiologica
Original articles
Published online: 2006-09-15

Abstract

Background: Atrial fibrillation (AF) is an arrhythmia with complex pathophysiological characteristics. The efficiency of various anti-tachyarrhythmic stimulation algorithms in patients with recurrent AF has become a subject of research and the aim of this analysis is to evaluate the success of treatment by continuous DDD(R) stimulation with an anti-tachyarrhythmic pacing algorithm in patients with paroxymal AF.
Methods: In the period 2002-2004 19 patients (10 females and 9 males), aged 45-74 (with a mean age of 64.2 ± 7.6), qualified for DDD(R) system implantation. The indication for implantation was tachy-brady syndrome with recurrent AF resistant to pharmacological treatment. All the patients had had at least three recurrences of symptomatic AF within the previous year. The follow-up period was 12 months. AF recurrences, outpatient visits and hospitalisation frequency were evaluated every 6 months and there were routine pacemaker controls. Baseline and final visit echocardiograms and a quality of life (QoL) questionnaire (SF-36) were obtained.
Results: One patient was excluded from the analysis owing to permanent AF with a final VVI pacing mode. In comparison with the pre-inclusion 12 months AF-related hospitalisation frequency within the 12-month follow-up period was 3.9 vs. 0.4 (p < 0.005) and outpatient visits 2.1 vs. 0.8 (p < 0.05). The mean atrial pacing percentage in all patients was 95.7% ± 2.9%, and the mode switch percentage during the first and second 6 month periods was 6.4% (1-50%, median 2) and 2.5% (0-7, median 2, NS) respectively. There were 483/month (0.44-5761, median 31) events defined as AF episodes during first 6 months and 84/month (0-480, median 17, NS) during the second 6 months. The AF burden was 1.92 days/month (7 h - 15 days, median 14 h), decreasing to 0.74 day/month (0-2.1 days, median 14 h, NS) in the second 6-month period. A significant 12-month improvement was achieved in QoL parameters.
Conclusions: An overdrive atrial algorithm can be a beneficial, safe and comfortable method in patients with paroxysmal drug-resistant AF and accepted indications for physiological pacing.

Abstract

Background: Atrial fibrillation (AF) is an arrhythmia with complex pathophysiological characteristics. The efficiency of various anti-tachyarrhythmic stimulation algorithms in patients with recurrent AF has become a subject of research and the aim of this analysis is to evaluate the success of treatment by continuous DDD(R) stimulation with an anti-tachyarrhythmic pacing algorithm in patients with paroxymal AF.
Methods: In the period 2002-2004 19 patients (10 females and 9 males), aged 45-74 (with a mean age of 64.2 ± 7.6), qualified for DDD(R) system implantation. The indication for implantation was tachy-brady syndrome with recurrent AF resistant to pharmacological treatment. All the patients had had at least three recurrences of symptomatic AF within the previous year. The follow-up period was 12 months. AF recurrences, outpatient visits and hospitalisation frequency were evaluated every 6 months and there were routine pacemaker controls. Baseline and final visit echocardiograms and a quality of life (QoL) questionnaire (SF-36) were obtained.
Results: One patient was excluded from the analysis owing to permanent AF with a final VVI pacing mode. In comparison with the pre-inclusion 12 months AF-related hospitalisation frequency within the 12-month follow-up period was 3.9 vs. 0.4 (p < 0.005) and outpatient visits 2.1 vs. 0.8 (p < 0.05). The mean atrial pacing percentage in all patients was 95.7% ± 2.9%, and the mode switch percentage during the first and second 6 month periods was 6.4% (1-50%, median 2) and 2.5% (0-7, median 2, NS) respectively. There were 483/month (0.44-5761, median 31) events defined as AF episodes during first 6 months and 84/month (0-480, median 17, NS) during the second 6 months. The AF burden was 1.92 days/month (7 h - 15 days, median 14 h), decreasing to 0.74 day/month (0-2.1 days, median 14 h, NS) in the second 6-month period. A significant 12-month improvement was achieved in QoL parameters.
Conclusions: An overdrive atrial algorithm can be a beneficial, safe and comfortable method in patients with paroxysmal drug-resistant AF and accepted indications for physiological pacing.
Get Citation

Keywords

paroxysmal atrial fibrillation; tachy-brady syndrome; overdrive; antitachyarrhythmic pacing

About this article
Title

The effect of anti-tachycardia atrial pacing in patients with recurrent paroxysmal atrial fibrillation

Journal

Cardiology Journal

Issue

Vol 13, No 7 (2006): Folia Cardiologica

Pages

590-595

Published online

2006-09-15

Bibliographic record

Folia Cardiol 2006;13(7):590-595.

Keywords

paroxysmal atrial fibrillation
tachy-brady syndrome
overdrive
antitachyarrhythmic pacing

Authors

Katarzyna Gepner
Maciej Sterliński
Mariusz Pytkowski
Aleksander Maciąg
Andrzej Przybylski
Alicja Kraska
Michał Lewandowski
Hanna Szwed

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl